Australia Nutraceuticals Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Australia Nutraceuticals Market Trends and Insights

Continued demand for immune-support products

Consumer emphasis on immune health continues to drive the growth of the nutraceuticals market in Australia. Post-pandemic, the focus on preventive health strategies persists, sustaining demand for immune-support supplements such as vitamin C, vitamin D, zinc, elderberry, echinacea, and probiotics. Increased awareness of seasonal illnesses, respiratory health, and overall well-being has led to the widespread adoption of daily immune supplementation across various age groups. Furthermore, advancements in delivery formats, including gummies, effervescent tablets, powders, and functional beverages, have enhanced accessibility and convenience, appealing to younger consumers and those with lifestyle-oriented preferences. As preventive healthcare gains further importance in Australia, immune-support products remain a key growth driver within the nutraceuticals market, creating more opportunities for innovation and market expansion. 

Increasing prevalence of chronic diseases such as diabetes

The increasing prevalence of chronic diseases, particularly diabetes, is a key factor driving the growth of the nutraceuticals market in Australia. As lifestyle-related health conditions become more widespread, consumers are increasingly seeking dietary supplements and functional nutrition products to enhance health management and mitigate associated risks. For example, the International Diabetes Federation reported that in 2024, 7.4% of adults were living with diabetes, underscoring the rising burden of metabolic disorders ^{[1]Source: International Diabetes Federation, "Australia", idf.org}. This growing prevalence is significantly boosting demand for nutraceutical products aimed at blood sugar management, cardiovascular health, weight control, and metabolic balance. Additionally, the adoption of preventive supplementation strategies under medical supervision by individuals with diabetes or pre-diabetic conditions is further driving consistent and sustained product demand, highlighting the critical role of nutraceuticals in proactive health management.

Popularity of plant-based and vegan nutraceuticals

The rising adoption of plant-based and vegan lifestyles is a significant driver of the nutraceuticals market in Australia. Growing consumer demand for clean-label, sustainably sourced, and cruelty-free products has increased the popularity of plant-derived vitamins, minerals, herbal extracts, algae-based omega-3, and botanical protein supplements. Consumers are actively seeking alternatives to animal-based ingredients such as gelatin capsules, fish oil, and whey protein. This has encouraged manufacturers to develop vegan capsules, pea and rice protein blends, and plant-based bioactives. The trend is further supported by greater awareness of environmental sustainability and ethical consumption, particularly influencing purchasing decisions among younger demographics and urban populations. Additionally, plant-based nutraceuticals are being marketed not only to vegans but also to flexitarians and health-conscious consumers, who view botanical ingredients as more natural and easier to digest.

Surge in sports nutrition and performance-enhancing supplements

The increasing adoption of fitness and active lifestyles is significantly driving the market, particularly in the areas of sports nutrition and performance-enhancing supplements. The growing participation in gym workouts, strength training, endurance sports, and recreational fitness activities is further accelerating demand for products such as protein powders, branched-chain amino acids (BCAAs), creatine, electrolyte blends, recovery supplements, and functional hydration solutions. According to the Australian Sports Commission (ASC), approximately 6.73 million people in Australia engaged in fitness or gym activities in 2024, highlighting a robust and expanding consumer base for sports-focused nutraceuticals ^{[2]Source: International Diabetes Federation, "Australia", idf.org}. This high level of participation continues to strongly enhance demand for products aimed at muscle recovery, endurance improvement, weight management, and performance optimization, creating sustained growth opportunities for the market.

Stringent regulatory framework

A stringent regulatory framework serves as a significant restraint in the Australian nutraceuticals market. Companies are required to enhance their compliance with strict safety, labeling, formulation, and health-claim regulations before commercializing their products. Oversight by authorities such as Food Standards Australia New Zealand (FSANZ), along with complementary therapeutic goods regulations, enforces rigorous standards on ingredient approvals, permissible health claims, contaminant limits, and advertising practices. These regulations often extend product development timelines and increase compliance costs, particularly for smaller manufacturers and new entrants. Additionally, frequent updates to ingredient standards, novel food approvals, and the need for evidence-based substantiation of functional claims may require reformulation or further clinical validation, delaying market entry.

Complex ingredient approval and reformulation risks

Complex ingredient approval processes and reformulation requirements present significant challenges in the Australian nutraceuticals market. Manufacturers must ensure that all active ingredients, excipients, and health claims meet regulatory standards prior to commercialization, which can extend product development timelines. Approval processes for novel foods, botanical extracts, probiotics, and bioactive compounds often demand extensive safety data, stability testing, and scientific validation. Reformulation challenges are particularly pronounced for global brands adapting products to the Australian market, as ingredient concentrations and health claims permitted elsewhere may not comply with local regulations. Changes in emerging safety evaluations or updated evidence requirements can lead to additional testing costs, packaging modifications, or even temporary product withdrawals. These complexities contribute to operational uncertainty, increase compliance costs, and may delay innovation cycles.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Functional Beverages Accelerate as Convenience Trumps Capsules

Dietary supplements accounted for 48.87% of the total market share in 2025, emerging as the leading category due to their integration into daily health routines and preventive healthcare practices. This position is supported by sustained consumer demand for vitamins, minerals, herbal supplements, probiotics, omega-3 fatty acids, and condition-specific formulations targeting areas such as immunity, bone health, heart health, digestive wellness, sleep, and cognitive function. Regulatory oversight by the Therapeutic Goods Administration enhances consumer confidence in listed (AUST L) products, fostering trust and encouraging repeat purchases. Growing awareness of micronutrient deficiencies, lifestyle-related health concerns, and the increasing focus on immune resilience continue to drive consistent growth in this category.

Functional beverages are projected to grow at a CAGR of 5.65% through 2031, reflecting a rising consumer preference for convenient, ready-to-consume wellness solutions that combine nutrition with functionality. This segment includes fortified drinks, protein beverages, and probiotic drinks that address needs such as immunity, hydration, gut health, cognitive performance, and sports recovery. Increasing demand for on-the-go nutrition, clean-label formulations, and reduced-sugar or naturally sweetened beverages is driving product innovation. The shift away from traditional carbonated soft drinks toward health-oriented alternatives further supports growth in this category. Additionally, advancements in ingredient technologies, such as stable probiotics, plant-based proteins, adaptogens, and nootropic compounds, are enabling manufacturers to deliver clinically relevant benefits in beverage formats.

By Distribution Channel: E-Commerce Disrupts Pharmacy Gatekeepers

Supermarkets and hypermarkets accounted for 42.54% of the total distribution share in 2025, maintaining their leading position due to strong consumer footfall, a wide product assortment, and convenience-driven purchasing behavior. Their competitive pricing strategies, frequent promotional campaigns, loyalty programs, and in-store visibility further bolster sales volumes. Additionally, these outlets offer the convenience of combining grocery and health-related purchases in a single trip, encouraging impulse buying and repeat purchases. The increasing availability of clean-label, plant-based, and condition-specific nutraceutical products within these stores has further enhanced category penetration among mainstream shoppers.

Online retail stores are projected to grow at a CAGR of 6.12% through 2031 in the Australia nutraceuticals market, supported by increasing digital engagement, convenience-led purchasing behavior, and the adoption of direct-to-consumer strategies by supplement brands. Australia's robust digital infrastructure significantly contributes to this growth. For example, according to the International Telecommunication Union (ITU), 96.1% of Australia’s population was using the internet in 2024, reflecting near-universal digital access and a highly connected consumer base ^{[3]Source: International Telecommunication Union (ITU), "Australia", datahub.itu.int}. This high level of internet penetration facilitates online discovery, product comparison, subscription models, and access to detailed ingredient transparency, all of which are key factors influencing nutraceutical purchasing decisions.

Geography Analysis

Australia's nutraceuticals market exhibits significant geographic concentration in major metropolitan areas such as Sydney, Melbourne, and Brisbane. These cities experience higher per-capita nutraceutical consumption compared to the national average, driven by elevated health awareness, dense retail networks, greater penetration of gyms and wellness centers, and a strong pharmacy presence. The well-developed omnichannel retail ecosystem in these urban hubs, encompassing supermarkets, specialty health stores, and digital commerce platforms, enhances product visibility and accessibility. Additionally, the multicultural demographics of these cities contribute to diversified demand across categories such as herbal supplements, probiotics, sports nutrition, and functional beverages, fostering category growth and product innovation.

Outside the primary metropolitan areas, cities like Perth, Adelaide, and Canberra are experiencing steady growth in nutraceutical adoption. These markets are witnessing increasing demand for condition-specific supplements, plant-based formulations, and sports nutrition products, supported by rising lifestyle awareness and the expansion of organized retail infrastructure. Canberra, in particular, demonstrates strong demand for premium and clinically validated formulations, attributed to higher levels of health literacy. Meanwhile, Perth and Adelaide benefit from the growth of pharmacy networks and supermarket-led health aisles, which further support market expansion.

In regional and semi-urban areas such as Newcastle, Wollongong, Townsville, and Hobart, the nutraceutical market is characterized by a higher proportion of elderly residents and a greater prevalence of chronic health conditions. This demographic profile drives above-average penetration of supplements targeting bone health, cardiovascular support, and immunity. However, the limited availability of specialty retail outlets in these areas restricts in-store product variety. As a result, pharmacy chains and online retail channels play a critical role in ensuring consistent product supply and accessibility. E-commerce and mail-order pharmacy services are increasingly essential in bridging geographic gaps and meeting consumer demand in these regions.

Regulatory Landscape

Australia does not regulate nutraceuticals under a single standalone category. Products are covered either under the Therapeutic Goods Administration (TGA) framework as therapeutic goods (including complementary medicines entered on the Australian Register of Therapeutic Goods as listed medicines, such as AUST L products) or under Food Standards Australia New Zealand (FSANZ) as foods regulated by the Australia New Zealand Food Standards Code, depending on composition, presentation, and intended claims. The TGA Food-Medicine Interface Guidance Tool is commonly used to determine the correct pathway and manage misclassification risk, particularly for borderline formats such as gummies, powders, and fortified beverages.

Regulatory requirements tighten around ingredients, labeling, and the substantiation of health claims. FSANZ requirements for nutrition and health claims (including Standard 1.2.7) shape how functional foods and beverages communicate benefits, while TGA-listed complementary medicines require sponsor-held evidence and remain subject to risk-based post-market compliance activity. As an update to compliance conditions, the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026 commenced on 1 March 2026, updating requirements for ingredients used in listed medicines, and the TGA published Compliance Principles for 2026 and 2027 to reinforce proactive, risk-based enforcement.

Market Opportunities and Future Outlook

Opportunities are concentrated in products and channels where consumers are already shifting behavior toward convenience, customization, and condition-led wellness. Functional beverages and sports-linked formulations fit demand tied to fitness and gym participation (6.73 million people in 2024, per the Australian Sports Commission), while online discovery and repeat purchase mechanics align with Australia having 96.1% internet penetration in 2024 (ITU). Within supplements, growth is most visible in compliant, format-led innovation (gummies, effervescents, ready-to-mix powders) that fits within TGA and FSANZ claim boundaries while improving adherence and ease of use.

On the supply side, building manufacturing capability and scaling infrastructure supports local manufacturing and ingredient innovation. Australia has 81 TGA-licensed complementary medicine manufacturing facilities (concentrated in New South Wales, Victoria, and Queensland), and the Central Coast Food Manufacturing Innovation Hub opened in July 2026 to help SMEs access commercial production facilities and specialist support for scaling. Industry programs and platforms such as the Food and Beverage Accelerator (FaBA) at the University of Queensland, along with government mechanisms including the Industry Growth Program and the National Reconstruction Fund, support advanced manufacturing and ingredient innovation, including precision fermentation and commercialization. Given industry commentary on heavy reliance on imported nutraceutical ingredients (around 90%), converting agricultural by-products into nutraceutical bioactives also presents a practical domestic sourcing opportunity, alongside export-oriented product development.